Practice Point | Published:

Does tamoxifen prophylaxis for breast cancer provide long-term prevention?

Nature Clinical Practice Oncology volume 4, pages 568569 (2007) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360: 817–824

  2. 2.

    et al. (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346: 1616–1622

  3. 3.

    et al. (2007) Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 99: 283–290

  4. 4.

    et al. (2007) Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst 99: 727–737

  5. 5.

    et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97: 1652–1662

Download references


The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information


  1. B Bonanni is Co-Director of the Division of Cancer Prevention and Genetics, M Lazzeroni is a Fellow, and U Veronesi is Scientific Director, at the European Institute of Oncology, Milan, Italy.

    • Bernardo Bonanni
    • , Matteo Lazzeroni
    •  & Umberto Veronesi


  1. Search for Bernardo Bonanni in:

  2. Search for Matteo Lazzeroni in:

  3. Search for Umberto Veronesi in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Umberto Veronesi.

About this article

Publication history





Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing